X
JAZZ icon

Xponance’s Jazz Pharmaceuticals JAZZ Stock Holding History

Xponance’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.44M Buy
7,633
+1,252
+20% +$219K 0.01% 639
2025
Q4 		$1.08M Sell
6,381
-1,270
-17% -$195K 0.01% 671
2025
Q3 		$1.01M Sell
7,651
-732
-9% -$87.8K 0.01% 702
2025
Q2 		$890K Sell
8,383
-211
-2% -$22.9K 0.01% 735
2025
Q1 		$1.07M Buy
8,594
+648
+8% +$84.5K 0.01% 670
2024
Q4 		$979K Buy
7,946
+1,195
+18% +$141K 0.01% 731
2024
Q3 		$752K Sell
6,751
-23
-0.3% -$2.52K 0.01% 804
2024
Q2 		$723K Sell
6,774
-6,418
-49% -$706K 0.01% 785
2024
Q1 		$1.59M Buy
13,192
+2,590
+24% +$317K 0.02% 580
2023
Q4 		$1.3M Sell
10,602
-346
-3% -$43.2K 0.02% 584
2023
Q3 		$1.42M Sell
10,948
-203
-2% -$27K 0.02% 551
2023
Q2 		$1.38M Buy
11,151
+2,782
+33% +$374K 0.02% 558
2023
Q1 		$1.22M Buy
8,369
+36
+0.4% +$5.33K 0.02% 585
2022
Q4 		$1.33M Buy
8,333
+957
+13% +$140K 0.02% 548
2022
Q3 		$983K Sell
7,376
-93
-1% -$14.1K 0.02% 585
2022
Q2 		$1.17M Buy
7,469
+598
+9% +$92.1K 0.02% 528
2022
Q1 		$1.07M Sell
6,871
-52
-0.8% -$7.55K 0.02% 574
2021
Q4 		$882K Sell
6,923
-17
-0.2% -$2.23K 0.01% 659
2021
Q3 		$904K Sell
6,940
-193
-3% -$29.2K 0.02% 609
2021
Q2 		$1.27M Buy
7,133
+1,171
+20% +$203K 0.02% 492
2021
Q1 		$980K Buy
5,962
+85
+1% +$14K 0.02% 486
2020
Q4 		$970K Sell
5,877
-6
-0.1% -$894 0.02% 476
2020
Q3 		$839K Buy
+5,883
New +$729K 0.02% 468

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Xponance's JAZZ Position: Q1 2026 in Review

Xponance increased its Jazz Pharmaceuticals (JAZZ) stake by 20% in Q1 2026, buying an estimated $219K and bringing the position to 7,633 shares worth $1.44M. The position accounts for 0.01% of the portfolio, ranked #639.

Xponance first reported a position in JAZZ in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.59M in Q1 2024. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Xponance held 7,633 shares of Jazz Pharmaceuticals worth $1.44M as of Q1 2026.
  • Xponance bought 1,252 Jazz Pharmaceuticals shares in Q1 2026, an estimated $219K.
  • Jazz Pharmaceuticals made up 0.01% of Xponance's portfolio in Q1 2026, its #639 holding.
  • Xponance first reported a position in Jazz Pharmaceuticals in Q3 2020 and has held it in 23 quarters since.
  • Xponance's Jazz Pharmaceuticals position peaked at $1.59M in Q1 2024.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.